Il ruolo degli esiti riferiti dal paziente nelle decisioni di rimborso e innovatività dei farmaci in Italia

The attention paid by regulatory authorities to patient-reported outcomes (PROs) and their related measures (PROMs) has progressively increased to allow for a more complete description of the patient’s health status. This work aimed at investigating the use of PROs/PROMs in relation to reimbursement...

Descripción completa

Detalles Bibliográficos
Autores principales: Malandrini, Francesco, Borroni, Cesare, Meregaglia, Michela, Sarra, Massimiliano, Ciani, Oriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923404/
https://www.ncbi.nlm.nih.gov/pubmed/36789181
http://dx.doi.org/10.33393/grhta.2023.2514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923404/
https://www.ncbi.nlm.nih.gov/pubmed/36789181
http://dx.doi.org/10.33393/grhta.2023.2514

Ejemplares similares